Clinical Trial Update: A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy [Phase 2]

View source ↗

Summary

Phase II trial evaluating imiquimod 5% cream for infantile capillary hemangioma has completed. The provided snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemangioma

Drugs mentioned

• Aldara (imiquimod)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Hemangioma, Capillary | Phase 2 | Status: COMPLETED